Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043420 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Kaja Troha und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, SI-1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Platelet-Rich Plasma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 275 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency, National Research, Development and Innovation Office (Hungary).
Abstract (Originalsprache)
The preparation of autologous platelet and extracellular vesicle-rich plasma (PVRP) has been explored in many medical fields with the aim to benefit from its healing potential. In parallel, efforts are being invested to understand the function and dynamics of PVRP that is complex in its composition and interactions. Some clinical evidence reveals beneficial effects of PVRP, while some report that there were no effects. To optimize the preparation methods, functions and mechanisms of PVRP, its constituents should be better understood. With the intention to promote further studies of autologous therapeutic PVRP, we performed a review on some topics regarding PVRP composition, harvesting, assessment and preservation, and also on clinical experience following PVRP application in humans and animals. Besides the acknowledged actions of platelets, leukocytes and different molecules, we focus on extracellular vesicles that were found abundant in PVRP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, SI-1000 Ljubljana, Slovenia.
- University of Ljubljana, Faculty of Medicine, SI-1000 Ljubljana, Slovenia.
- University of Ljubljana, Laboratory of Clinical Biophysics, Faculty of Health Sciences, SI-1000 Ljubljana, Slovenia.
- Department of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, SI-1000 Ljubjana, Slovenia.
- Department of Orthopedic Surgery, University Medical Centre, Zaloška 9, SI-1000 Ljubljana, Slovenia.
- MD-RI Institute for Materials Research in Medicine, Bohoričeva 5, SI-1000 Ljubljana, Slovenia.
ORCID-Profile: Domen Vozel, Matevž Arko, Matic Kisovec, Ljubiša Pađen, Samo Penič, Nejc Steiner, Aleš Iglič, Damjana Drobne, Ksenija Kogej, Saba Battelino, Veronika Kralj-Iglič
Förderung
- Slovenian Research Agency
- National Research, Development and Innovation Office (Hungary)
Zitieren
APA
Troha, K., Vozel, D., Arko, M., Bedina Zavec, A., Dolinar, D., Hočevar, M., Jan, Z., Kisovec, M., Kocjančič, B., Pađen, L., Pajnič, M., Penič, S., Romolo, A., Repar, N., Spasovski, V., Steiner, N., Šuštar, V., Iglič, A., Drobne, D., …, & Kralj-Iglič, V. (2023). Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043420
Vancouver
Troha K, Vozel D, Arko M, Bedina Zavec A, Dolinar D, Hočevar M, et al. Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043420
BibTeX
@article{Troha2023,
author = {Troha, Kaja and Vozel, Domen and Arko, Matevž and Bedina Zavec, Apolonija and Dolinar, Drago and Hočevar, Matej and Jan, Zala and Kisovec, Matic and Kocjančič, Boštjan and Pađen, Ljubiša and Pajnič, Manca and Penič, Samo and Romolo, Anna and Repar, Neža and Spasovski, Vesna and Steiner, Nejc and Šuštar, Vid and Iglič, Aleš and Drobne, Damjana and Kogej, Ksenija and Battelino, Saba and Kralj-Iglič, Veronika},
title = {Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043420}
}
EUVIMED